The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durvalumab treatment initiation delays in patients with unresectable stage III non–small cell lung cancer treated at Veterans Health Administration facilities.
 
Paromita Datta
No Relationships to Disclose
 
Amanda Moore
No Relationships to Disclose
 
Christopher R Frei
Research Funding - AstraZeneca/MedImmune (Inst)
 
Kelly R Reveles
Employment - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Ferring
Research Funding - AstraZeneca/MedImmune (Inst)
 
Lance Brannman
Employment - AstraZeneca/MedImmune
Stock and Other Ownership Interests - AstraZeneca/MedImmune; Sonic Healthcare
 
Ion Cotarla
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Consulting or Advisory Role - Gerson Lehrman Group
 
Andrew Frankart
Other Relationship - AstraZeneca/MedImmune
 
Tiernan Mulrooney
Employment - AstraZeneca/MedImmune
Stock and Other Ownership Interests - AstraZeneca/MedImmune
 
Munaf Alkadimi
No Relationships to Disclose
 
Jennifer Whitehead
No Relationships to Disclose
 
Kathleen Franklin
No Relationships to Disclose
 
Renee Reichelderfer
No Relationships to Disclose
 
Madison H. Williams
No Relationships to Disclose
 
Ryan A. Williams
No Relationships to Disclose
 
Sarah Allison Smith
No Relationships to Disclose
 
Xavier Jones
Research Funding - AstraZeneca/MedImmune (Inst)
 
Zohra Nooruddin
Employment - PPD (I)
Research Funding - AstraZeneca/MedImmune